{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["benign prostatic hyperplasia", "clinical efficacy", "medicinal plants", "phytotherapy", "preclinical studies", "safety issues", "saw palmetto"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34885733", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "25"}], "Language": ["eng"], "ELocationID": ["7141", "10.3390/molecules26237141"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "23", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "25"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Treatment of Benign Prostatic Hyperplasia by Natural Drugs.", "Abstract": {"AbstractText": ["Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5\u03b1-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "Csik\u00f3s", "ForeName": "Eszter", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "Horv\u00e1th", "ForeName": "Adrienn", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "\u00c1cs", "ForeName": "Kamilla", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "Papp", "ForeName": "N\u00f3ra", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "Bal\u00e1zs", "ForeName": "Vikt\u00f3ria Lilla", "Initials": "VL"}, {"Identifier": ["0000-0002-0560-3762"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ljubljana, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, SI-1000 Ljubljana, Slovenia."}], "LastName": "Dolenc", "ForeName": "Marija Sollner", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ljubljana, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, SI-1000 Ljubljana, Slovenia."}], "LastName": "Kenda", "ForeName": "Ma\u0161a", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ljubljana, Department of Pharmaceutical Biology, Faculty of Pharmacy, SI-1000 Ljubljana, Slovenia."}], "LastName": "Ko\u010devar Glava\u010d", "ForeName": "Nina", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, SK-832-32 Bratislava, Slovakia."}], "LastName": "Nagy", "ForeName": "Milan", "Initials": "M"}, {"Identifier": ["0000-0001-9310-4957"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Group of Pharmaco-Toxicological Analysis (PTA Lab), Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy."}], "LastName": "Protti", "ForeName": "Michele", "Initials": "M"}, {"Identifier": ["0000-0002-0644-9461"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Group of Pharmaco-Toxicological Analysis (PTA Lab), Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy."}], "LastName": "Mercolini", "ForeName": "Laura", "Initials": "L"}, {"Identifier": ["0000-0001-5344-0294"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "Horv\u00e1th", "ForeName": "Gy\u00f6rgyi", "Initials": "G"}, {"Identifier": ["0000-0002-8590-3203"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, University of P\u00e9cs, H-7624 P\u00e9cs, Hungary."}], "LastName": "Farkas", "ForeName": "\u00c1gnes", "Initials": "\u00c1"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "On Behalf Of The Oemonom"}], "GrantList": [{"GrantID": "Project No. 2020-1-CZ01-KA203-078218", "Agency": "Erasmus+ Programme of the European Union, Key Action 2: Strategic Partnerships", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogens"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "08J2K08A3Y", "NameOfSubstance": "Dihydrotestosterone"}, {"RegistryNumber": "3XMK78S47O", "NameOfSubstance": "Testosterone"}, {"RegistryNumber": "EC 1.3.99.5", "NameOfSubstance": "3-Oxo-5-alpha-Steroid 4-Dehydrogenase"}, {"RegistryNumber": "J7WWH9M8QS", "NameOfSubstance": "saw palmetto extract"}], "MeshHeadingList": [{"QualifierName": ["drug effects", "genetics"], "DescriptorName": "3-Oxo-5-alpha-Steroid 4-Dehydrogenase"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["blood"], "DescriptorName": "Dihydrotestosterone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Estrogens"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Prostatic Hyperplasia"}, {"QualifierName": ["chemistry"], "DescriptorName": "Serenoa"}, {"QualifierName": ["blood"], "DescriptorName": "Testosterone"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Madersbachera S., Alivizatosb G., Nordling J., Nordling J., Sanz C.R., Emberton M., Rosette J. EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines) Eur. Urol. 2004;46:547\u2013554. doi: 10.1016/j.eururo.2004.07.016.", "ArticleIdList": ["10.1016/j.eururo.2004.07.016", "15474261"]}, {"Citation": "De la Rosettea J.J.M.C.H., Alivizatosb G., Madersbacher S. EAU Guidelines on Benign Prostatic Hyperplasia (BPH) Eur. Urol. 2001;40:256\u2013263. doi: 10.1159/000049784.", "ArticleIdList": ["10.1159/000049784", "11684840"]}, {"Citation": "Yanoshak S., Roehrborn C., Girman C., Jaffe J.S., Ginsberg P.C., Harkaway R.C. Use of a prostate model to assist in training for digital rectal examination. Urology. 2000;55:690\u2013693. doi: 10.1016/S0090-4295(99)00606-8.", "ArticleIdList": ["10.1016/S0090-4295(99)00606-8", "10792082"]}, {"Citation": "Allkanjari O., Vitalone A. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sci. 2015;126:42\u201356. doi: 10.1016/j.lfs.2015.01.023.", "ArticleIdList": ["10.1016/j.lfs.2015.01.023", "25703069"]}, {"Citation": "Jonler M., Riehmann M., Brinkmann R., Bruskewitz R.C. Benign prostatic hyperplasia. Endocrinol. Metab. Clin. N. Am. 1994;4:795\u2013807. doi: 10.1016/S0889-8529(18)30068-9.", "ArticleIdList": ["10.1016/S0889-8529(18)30068-9", "7535688"]}, {"Citation": "Anderson J.B., Roehrborn C.G., Schalken J.A., Emberton M. The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk. Eur. Urol. 2001;39:390\u2013399. doi: 10.1159/000052475.", "ArticleIdList": ["10.1159/000052475", "11306876"]}, {"Citation": "Isaacs J.T. Etiology of benign prostatic hyperplasia. Eur. Urol. 1994;25:6\u20139. doi: 10.1159/000475324.", "ArticleIdList": ["10.1159/000475324", "7507055"]}, {"Citation": "Grant E.S., Brown T., Roach A., Williams B.C., Habib F.K. In vitro expression of endothelin-1 (ET-1) and the ETA and ETB ET receptors by the prostatic epithelium and stroma. J. Clin. Endocrinol. Metab. 1997;82:508\u2013513. doi: 10.1210/jc.82.2.508.", "ArticleIdList": ["10.1210/jc.82.2.508", "9024245"]}, {"Citation": "Fagelman E., Lowe F.C. Herbal medications in the treatment of benign prostatic hyperplasia (BPH) Urol. Clin. N. Am. 2002;29:23\u201329. doi: 10.1016/S0094-0143(02)00015-0.", "ArticleIdList": ["10.1016/S0094-0143(02)00015-0", "12109350"]}, {"Citation": "Oelke M., Bachmann A., Descazeaud A., Emberton M., Gravas S., Michel M.C., N\u2019Dow J., Nordling J., de la Rosette J.J. Europe protocol: Guidelines EAU Guidelines on the Treatment and Follow-up of-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur. Urol. 2013;64:118\u2013140. doi: 10.1016/j.eururo.2013.03.004.", "ArticleIdList": ["10.1016/j.eururo.2013.03.004", "23541338"]}, {"Citation": "The Ministry of Human Resources\u2019 Professional Guideline on Pharmacist Advice on Self-Management of Benign Prostatic Hyperplasia.  [(accessed on 21 January 2021)].  Available online:  https://www.hbcs.hu/uploads/jogszabaly/2695/fajlok/EMMI_szakmai_iranyelve_prosztatamegnagyobbodas.pdf."}, {"Citation": "American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH) 2010.  [(accessed on 28 January 2021)].  Available online:  http://www.auanet.org/education/guidelines/benign-prostatic-hyperplasia.cfm."}, {"Citation": "Rosette J., Alivizatos G., Madersbacher S., Sanz S.R., Emberton M., Nordling J. Guidelines on Benign Prostatic Hyperplasia. European Association of Urology. 2004.  [(accessed on 21 January 2021)].  Available online:  https://uroweb.org/wp-content/uploads/EAU-Guidelines-BPH-2004.pdf."}, {"Citation": "McVary K.T. Surgical Treatment of Benign Prostatic Hyperplasia (BPH)  [(accessed on 21 January 2021)].  Available online:  https://www.uptodate.com/contents/surgical-treatment-of-benign-prostatic-hyperplasia-bph/print?search=BPH%20dietary&topicRef=6891&source=see_link."}, {"Citation": "McVary K.T. Medical Treatment of Benign Prostatic Hyperplasia.  [(accessed on 21 January 2021)].  Available online:  https://www.uptodate.com/contents/medical-treatment-of-benign-prostatic-hyperplasia?search=BPH&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."}, {"Citation": "Pagano E., Laudato M., Griffo M., Capasso R. Phytotherapy of Benign Prostatic Hyperplasia. A Minireview. Phytother. Res. 2014;28:949\u2013955. doi: 10.1002/ptr.5084.", "ArticleIdList": ["10.1002/ptr.5084", "25165780"]}, {"Citation": "Tacklind J., MacDonald R., Rutks I., Stanke J.U., Wilt T.J. Serenoa repens for benign prostatic hyperplasia (Review) Cochrane Database Syst. Rev. 2012;12:14\u201323.", "ArticleIdList": ["PMC7084061", "23235581"]}, {"Citation": "Wilt T.J., Ishani A., MacDonald R., Stark G., Mulrow C.D., Lau J. Beta-sitosterols for benign prostatic hyperplasia (Review) Cochrane Database Syst. Rev. 1999;3:10\u201343.", "ArticleIdList": ["PMC8407049", "10796740"]}, {"Citation": "Wilt T., Ishani A., Mac Donald R., Rutks I., Stark G. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 2002;1998:CD001044. doi: 10.1002/14651858.CD001044.", "ArticleIdList": ["10.1002/14651858.CD001044", "PMC7032619", "11869585"]}, {"Citation": "Miao L., Yun X., Yang X., Jia S., Jiao C., Shao R., Hao J., Chang Y., Fan G., Zhang J., et al. An inhibitory effect of Berberine from herbal Coptis chinensis Franch on rat detrusor contraction in benign prostatic hyperplasia associated with lower urinary tract symptoms. J. Ethnopharmacol. 2021;268:113666. doi: 10.1016/j.jep.2020.113666.", "ArticleIdList": ["10.1016/j.jep.2020.113666", "33301912"]}, {"Citation": "Ma X., Meredith J. Chapter 5.5: Herbal medicine for the treatment of andrological diseases: Traditional Chinese Medicine. In: Henkel R., Agarwal A., editors. Herbal Medicine in Andrology. An Evidence-Based Update. 1st ed. Elsevier; Amsterdam, The Netherlands: 2020. pp. 147\u2013163."}, {"Citation": "Skinner M. Encyclopedia of Reproduction. 2nd ed. Elsevier; Amsterdam, The Netherlands: 2018. pp. 336\u2013339."}, {"Citation": "Lepor H. Medical Treatment of Benign Prostatic Hyperplasia.  [(accessed on 21 January 2021)];Rev. Urol. 2011 13:20\u201333. Available online:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151584/", "ArticleIdList": ["PMC3151584", "21826125"]}, {"Citation": "Zitoun O.A., Farhat A.M.N., Mohamed M.A., Mohammad Hamad M.R., Aramini B., Haider K.H. Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors. Eur. J. Pharmacol. 2020;883:173301. doi: 10.1016/j.ejphar.2020.173301.", "ArticleIdList": ["10.1016/j.ejphar.2020.173301", "32592768"]}, {"Citation": "Pattanaik S., Mavuduru R.S., Panda A., Mathew J.L., Agarwal M.M., Hwang E.C., Lyon J.A., Singh S.K., Mandal A.K. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia (Review) Cochrane Database Syst. Rev. 2018;11:CD010060.", "ArticleIdList": ["PMC6517182", "30480763"]}, {"Citation": "Reich O., Seitz M., Gratzke C., Schlenker B., Walther S., Stief C. Benignes Prostatasyndrom. Urologe. 2010;49:113\u2013125. doi: 10.1007/s00120-009-2183-1.", "ArticleIdList": ["10.1007/s00120-009-2183-1", "20033128"]}, {"Citation": "Jung J.H., Reddy B., McCutcheon K.A., Borofsky M., Narayan V., Kim M.H., Dahm P. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia (Review) Cochrane Database Syst. Rev. 2019;5:128\u2013132.", "ArticleIdList": ["PMC6535104", "31128077"]}, {"Citation": "Kang T.W., Jung J.H., Hwang E.C., Borofsky M., Kim M.H., Dahm P. Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia (Review) Cochrane Database Syst. Rev. 2020;3:132\u2013151.", "ArticleIdList": ["PMC7093307", "32212174"]}, {"Citation": "Dotto J.M., Chacha J.S. The potential of pumpkin seeds as a functional food ingredient: A review. Sci. Afr. 2020;10:1\u201314. doi: 10.1016/j.sciaf.2020.e00575.", "ArticleIdList": ["10.1016/j.sciaf.2020.e00575"]}, {"Citation": "PDR for Herbal Medicines. 3rd. ed. Thomson PDR; Montvale, NJ, USA: 2004."}, {"Citation": "Stovel D.D. Pumpkin: A Super Food for All 12 Months of the Year. Storey Publishing LLC; North Adams, MA, USA: 2005."}, {"Citation": "Whitaker T.W., Davis G.N. Cucurbits: Botany, Cultivation and Utilization. Interscience Publication Inc.; New York, NY, USA: 1962."}, {"Citation": "Lloyd J.U., Felter H.W. King\u2019s American Dispensatory. 18th ed. Eclectic Medical Publications; Sandy, OR, USA: 1998. pp. 1655\u20131659."}, {"Citation": "Caili F., Huan S., Quanhong L. A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Hum. Nutr. 2006;61:73\u201380. doi: 10.1007/s11130-006-0016-6.", "ArticleIdList": ["10.1007/s11130-006-0016-6", "16758316"]}, {"Citation": "Matus Z., Molnar P., Szabo L.G. Main carotenoids in pressed seeds (Cucurbitae semen) of oil pumpkin (Cucurbita pepo convar. pepo var. styriaca) (article in Hungarian) Acta Pharm. Hung. 1993;63:247\u2013256.", "ArticleIdList": ["8249609"]}, {"Citation": "Mansour E.H., Dworschak E., Gergely A., H\u00f3v\u00e1ri J., Pollhamer Z. Pumpkin and canola seed proteins and bread quality. Acta Aliment. 1999;28:59\u201370."}, {"Citation": "Glew R.H., Glew R.S., Chuang L.T., Huang Y.S., Millson M., Constans D., Vanderjagt D.J. Amino acid, mineral and fatty acid content of pumpkin seeds (Cucurbita spp.) and Cyperus esculentus nuts in the Republic of Niger. Plant Foods Hum. Nutr. 2006;61:51\u201356. doi: 10.1007/s11130-006-0010-z.", "ArticleIdList": ["10.1007/s11130-006-0010-z", "16770692"]}, {"Citation": "Yadav M., Jain S., Tomar R., Prasad G.B.K., Yadav H. Medicinal and biological potential of pumpkin: An updated review. Nutr. Res. Rev. 2010;23:184\u2013190. doi: 10.1017/S0954422410000107.", "ArticleIdList": ["10.1017/S0954422410000107", "21110905"]}, {"Citation": "Broznic D., Canadi Jure\u0161ic G., Milin C. Involvement of \u03b1-, \u03b3-and \u03b4-tocopherol isomers from pumpkin (Cucurbita pepo L.) seed oil or oil mixtures in the biphasic DPPH disappearance kinetics. Food Technol. Biotechnol. 2016;54:200\u2013210. doi: 10.17113/ftb.54.02.16.4063.", "ArticleIdList": ["10.17113/ftb.54.02.16.4063", "PMC5105620", "27904410"]}, {"Citation": "Naziri E., Mitic M.N., Tsimidou M.Z. Contribution of tocopherols and squalene to the oxidative stability of cold-pressed pumkin seed oil (Cucurbita pepo L.) Eur. J. Lipid Sci. Technol. 2016;118:898\u2013905. doi: 10.1002/ejlt.201500261.", "ArticleIdList": ["10.1002/ejlt.201500261"]}, {"Citation": "Abou-Zeid S.M., Abu Bakr H.O., Mohamed M.A., El-Bahrawy A. Ameliorative effect of pumpkin seed oil against emamectin induced toxicity in mice. Biomed. Pharmacother. 2018;98:242\u2013251. doi: 10.1016/j.biopha.2017.12.040.", "ArticleIdList": ["10.1016/j.biopha.2017.12.040", "29268245"]}, {"Citation": "Akta N., Uzla T., Tun\u00e7il Y.E. Pre-roasting treatments significantly impact thermal and kinetic characteristics of pumpkin seed oil. Thermochim. Acta. 2018;669:109\u2013115. doi: 10.1016/j.tca.2018.09.012.", "ArticleIdList": ["10.1016/j.tca.2018.09.012"]}, {"Citation": "Aghaei S., Nikzad H., Taghizadeh M., Tameh A., Taherian A., Moravveji A. Protective effect of Pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with Cyclophosphamide. Andrologia. 2014;8:927\u2013935. doi: 10.1111/and.12175.", "ArticleIdList": ["10.1111/and.12175", "24124763"]}, {"Citation": "Jayaprakasam B., Seeram N.P., Nair M.G. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett. 2003;189:11\u201316. doi: 10.1016/S0304-3835(02)00497-4.", "ArticleIdList": ["10.1016/S0304-3835(02)00497-4", "12445672"]}, {"Citation": "Balbino S., Doric M., Vidakovic S., Kraljic K., \u0160kevin D., Drakula S., Voucko B., Cukelj N., Obranovic M., Curic D. Application of cryogenic grinding pretreatment to enhance extractability of bioactive molecules from pumpkin seed cake. J. Food Process Eng. 2019;42:13\u201330. doi: 10.1111/jfpe.13300.", "ArticleIdList": ["10.1111/jfpe.13300"]}, {"Citation": "Cho Y.H., Lee S.Y., Jeong D.W., Choi E.J., Kim Y.J., Lee J.G., Cha H.S. Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: A randomized, double-blind, placebo-controlled trial. Evid.-Based Compl. Alt. Med. 2014;2014:1\u20137. doi: 10.1155/2014/549721.", "ArticleIdList": ["10.1155/2014/549721", "PMC4017725", "24864154"]}, {"Citation": "Ezea B.O., Ogbole O.O., Ajaiyeoba E.O. In vitro anthelmintic properties of root extracts of three Musa species. J. Pharm. Bioresour. 2019;16:145\u2013151. doi: 10.4314/jpb.v16i2.8.", "ArticleIdList": ["10.4314/jpb.v16i2.8"]}, {"Citation": "Fruhwirth G.O., Wenzl T., El-Toukhy R., Wagner F.S., Hermetter A. Fluorescence screening of antioxidant capacity in pumpkin seed oils and other natural oils. Eur. J. Lipid Sci. Technol. 2003;105:266\u2013274. doi: 10.1002/ejlt.200390055.", "ArticleIdList": ["10.1002/ejlt.200390055"]}, {"Citation": "Alhakamy N.A., Fahmy U.A., Ahmed O.A.A. Attenuation of benign prostatic hyperplasia by optimized tadalafil loaded pumpkin seed oil-based self nanoemulsion: In vitro and in vivo evaluation. Pharmaceutics. 2019;12:640. doi: 10.3390/pharmaceutics11120640.", "ArticleIdList": ["10.3390/pharmaceutics11120640", "PMC6955804", "31805693"]}, {"Citation": "Gossell-Williams M., Davis A., O\u2019Connor N. Inhibition of testosterone-induced hyperplasia of the prostate of sprague-dawley rats by pumpkin seed oil. J. Med. Food. 2006;9:284\u2013286. doi: 10.1089/jmf.2006.9.284.", "ArticleIdList": ["10.1089/jmf.2006.9.284", "16822218"]}, {"Citation": "Ren S., Ouyang D.Y., Saltis M., Xu L.H., Zha Q.B., Cai Y.Y., He X.H. Anti-proliferative effect of 23, 24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation. Cancer Chemother. Pharmacol. 2012;70:415\u2013424. doi: 10.1007/s00280-012-1921-z.", "ArticleIdList": ["10.1007/s00280-012-1921-z", "22814677"]}, {"Citation": "Zhang X., Ouyang J.Z., Zhang Y.S., Tayalla B., Zhou X.C., Zhou S.W., Tongii J. Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: An experimental study. Med. Univ. 1994;14:235\u2013238.", "ArticleIdList": ["7760436"]}, {"Citation": "Fornara P., Madersbacher S., Vahlensieck W., Bracher F., Romics I., Kil P. Phytotherapy adds to the therapeutic armamentarium for the treatment of mild-to-moderate lower urinary tract symptoms in men. Urol. Int. 2020;104:333\u2013342. doi: 10.1159/000504611.", "ArticleIdList": ["10.1159/000504611", "31852006"]}, {"Citation": "Gazova A., Valaskova S., Zufkova V., Castejon A.M., Kyselovic J. Clinical study of effectiveness and safety of CELcomplex((R)) containing Cucurbita Pepo Seed extract and Flax and Casuarina on stress urinary incontinence in women. J. Tradit. Complement. Med. 2019;9:138\u2013142. doi: 10.1016/j.jtcme.2017.10.005.", "ArticleIdList": ["10.1016/j.jtcme.2017.10.005", "PMC6435946", "30963048"]}, {"Citation": "Lower C.F. Phytotherapy in the management of benign prostatic hyperplasia. Urology. 2001;58:71\u201377.", "ArticleIdList": ["11750257"]}, {"Citation": "Tsai Y.S., Tong Y.C., Cheng J.T., Lee C.H., Yang F.S., Lee H.Y. Pumpkin seed oil and phytosterol-F can block testosterone/prazosin-induced prostate growth in rats. Urol. Int. 2006;77:269\u2013274. doi: 10.1159/000094821.", "ArticleIdList": ["10.1159/000094821", "17033217"]}, {"Citation": "Steenkamp V. Phytomedicines for the prostate. Fitoterapia. 2003;74:545\u2013552. doi: 10.1016/S0367-326X(03)00155-2.", "ArticleIdList": ["10.1016/S0367-326X(03)00155-2", "12946716"]}, {"Citation": "Vahlensieck W.J., Fabricius P.G., Hell U. Drug therapy of benign prostatic hyperplasia. Fortschritte der Medizin. 1996;114:407\u2013411.", "ArticleIdList": ["9036092"]}, {"Citation": "Carbin B.E., Larson B., Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. Br. J. Urol. 1990;66:639\u2013641. doi: 10.1111/j.1464-410X.1990.tb07199.x.", "ArticleIdList": ["10.1111/j.1464-410X.1990.tb07199.x", "1702340"]}, {"Citation": "Blumenthal M. The Complete German Commission E Monographs. American Botanical Council; Austin, TX, USA: 1998."}, {"Citation": "Schiebel-Schlosser G., Friederich M. Phytotherapy of BPH with pumpkin seeds-a multicenter clinical trial. Z. Phytother. 1998;19:71\u201376."}, {"Citation": "Vahlensieck W., Theurer C., Pfitzer E., Patz B., Banik N., Engelmann U. Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study. Urol. Int. 2015;94:286\u2013295. doi: 10.1159/000362903.", "ArticleIdList": ["10.1159/000362903", "25196580"]}, {"Citation": "Coulson S., Rao A., Beck S.L., Steels E., Gramotnev H., Vitetta L. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: A herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. Complement. Ther. Med. 2013;21:172\u2013179. doi: 10.1016/j.ctim.2013.01.007.", "ArticleIdList": ["10.1016/j.ctim.2013.01.007", "23642948"]}, {"Citation": "Leibbrand M., Siefer S., Sch\u00f6n C., Perrinjaquet-Moccetti T., Kompek A., Csernich A., Bucar F., Kreuter M.H. Effects of an oil-free hydroethanolic pumpkin seed extract on symptom frequency and severity in men with benign prostatic hyperplasia: A pilot study in humans. J. Med. Food. 2019;22:551\u2013559. doi: 10.1089/jmf.2018.0106.", "ArticleIdList": ["10.1089/jmf.2018.0106", "PMC6590724", "31017505"]}, {"Citation": "Shirvan M.K., Mahboob M.R., Masuminia M., Mohammadi S. Pumpkin seed oil (prostafit) or prazosin? Which one is better in the treatment of symptomatic benign prostatic hyperplasia. J. Pak. Med. Assoc. 2014;64:683\u2013685.", "ArticleIdList": ["25252490"]}, {"Citation": "Hong H., Kim C.S., Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr. Res. Pract. 2009;4:323\u2013327. doi: 10.4162/nrp.2009.3.4.323.", "ArticleIdList": ["10.4162/nrp.2009.3.4.323", "PMC2809240", "20098586"]}, {"Citation": "Friederich M., Theurer C., Schiebel-Schlosser G. Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients. Forsch Komplementarmed Klass Naturheilkd. 2000;7:200\u2013204.", "ArticleIdList": ["11025395"]}, {"Citation": "Dvorkin L., Song K.Y. Herbs for benign prostatic hyperplasia. Ann. Farmacother. 2002;36:1443\u20131452. doi: 10.1345/aph.1A228.", "ArticleIdList": ["10.1345/aph.1A228", "12196065"]}, {"Citation": "EU Herbal Monograph: Cucurbitae semen.  [(accessed on 20 May 2021)].  Available online:  https://www.ema.europa.eu/en/medicines/herbal/cucurbitae-semen."}, {"Citation": "Granica S., Piwowarski J.P., Czerwi\u0144ska M.E., Kiss A.K. Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): A review. J. Ethnopharmacol. 2014;156:316\u2013346. doi: 10.1016/j.jep.2014.08.036.", "ArticleIdList": ["10.1016/j.jep.2014.08.036", "25196824"]}, {"Citation": "Vitalone A., Allkanjari O. Epilobium spp: Pharmacology and Phytochemistry. Phytother. Res. 2018;32:1229\u20131240. doi: 10.1002/ptr.6072.", "ArticleIdList": ["10.1002/ptr.6072", "29575111"]}, {"Citation": "Dreger M., Adamczak A., Seidler-\u0141o\u017cykowska K., Wielgus K. Pharmacological properties of fireweed (Epilobium angustifolium L.) and bioavailability of ellagitannins. A review. Herba Polonica. 2020;66:52\u201364. doi: 10.2478/hepo-2020-0001.", "ArticleIdList": ["10.2478/hepo-2020-0001"]}, {"Citation": "Kadam P., Patil M., Yadav K. A Review on Phytopharmacopial Potential of Epilobium angustifolium. Pharm. J. 2018;10:1076\u20131078. doi: 10.5530/pj.2018.6.181.", "ArticleIdList": ["10.5530/pj.2018.6.181"]}, {"Citation": "Schepetkin I.A., Ramstead A.G., Kirpotina L.N., Voyich J.M., Jutila M.A., Quinn M.T. Therapeutic Potential of Polyphenols from Epilobium angustifolium (Fireweed) Phytother. Res. 2016;30:1287\u20131297. doi: 10.1002/ptr.5648.", "ArticleIdList": ["10.1002/ptr.5648", "PMC5045895", "27215200"]}, {"Citation": "Karakaya S., S\u00fcntar I., Yakinci O.F., Sytar O., Ceribasi S., Dursunoglu B., Ozbek H., Guvenalp Z. In vivo bioactivity assessment on Epilobium species: A particular focus on Epilobium angustifolium and its components on enzymes connected with the healing process. J. Ethnopharmacol. 2020;262:113207. doi: 10.1016/j.jep.2020.113207.", "ArticleIdList": ["10.1016/j.jep.2020.113207", "32730870"]}, {"Citation": "Dacrema M., Sommella E., Santarcangelo C., Bruno B., Marano M.G., Insolia V., Saviano A., Campiglia P., Stornaiuolo M., Daglia M. Metabolic profiling, in vitro bioaccessibility and in vivo bioavailability of a commercial bioactive Epilobium angustifolium L. extract. Biomed Pharmacother. 2020;131:110670. doi: 10.1016/j.biopha.2020.110670.", "ArticleIdList": ["10.1016/j.biopha.2020.110670", "32896677"]}, {"Citation": "Yoshida T., Yoshimura M., Amakura Y. Chemical and Biological Significance of Oenothein B and Related Ellagitannin Oligomers with Macrocyclic Structure. Molecules. 2018;23:552. doi: 10.3390/molecules23030552.", "ArticleIdList": ["10.3390/molecules23030552", "PMC6017083", "29498647"]}, {"Citation": "Kujawski R.P.M., Mrozikiewicz P.\u0141., Miko\u0142ajczak G., Kuzio A., Bogacz J., Cichocka J., Bartkowiak-Wieczorek E., Grze\u015bkowiak I., Bobkiewicz-Koz\u0142owska U.T., Czerny B. Influence of Epilobium angustifolium and Serenoa repens extracts on cytochrome 2D2 and 3A1 expression level in rats. Herba Polonica. 2010;56:39\u201351."}, {"Citation": "Karakurt S., Semiz A., Celik G., Gencler-Ozkan A.M., Sen A., Adali O. Epilobium hirsutum alters xenobiotic metabolizing CYP1A1, CYP2E1, NQO1 and GPx activities, mRNA and protein levels in rats. Pharm. Biol. 2013;51:650\u2013658. doi: 10.3109/13880209.2012.762404.", "ArticleIdList": ["10.3109/13880209.2012.762404", "23527956"]}, {"Citation": "Celik G., Semiz A., Karakurt S., Gencler-Ozkan A.M., Arslan S., Adali O., Sen A. Inhibitory action of Epilobium hirsutum extract and its constituent ellagic acid on drug-metabolizing enzymes. Eur. J. Drug Metab. Pharmacokinet. 2016;2:109\u2013116. doi: 10.1007/s13318-014-0238-1.", "ArticleIdList": ["10.1007/s13318-014-0238-1", "25425117"]}, {"Citation": "Bassey K., Viljoen A., Combrinck S., Choi Y.H. New phytochemicals from the corms of medicinally important South African Hypoxis species. Phytochem. Lett. 2014;10:119\u2013125. doi: 10.1016/j.phytol.2014.09.014.", "ArticleIdList": ["10.1016/j.phytol.2014.09.014"]}, {"Citation": "Zulfiqar F., Khan S.I., Ali Z., Wang Y.-H., Ross S.A., Viljoen A.M., Khan I.A. Norlignan glucosides from Hypoxis hemerocallidea and their potential in vitro anti-inflammatory activity via inhibition of iNOS and NF-\u03baB. Phytochemistry. 2020;172:112273. doi: 10.1016/j.phytochem.2020.112273.", "ArticleIdList": ["10.1016/j.phytochem.2020.112273", "31981957"]}, {"Citation": "FoodData Central.  [(accessed on 19 May 2021)]; Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/170457/nutrients."}, {"Citation": "Stahl W., Sies H. Lycopene: A biologically important carotenoid for humans? Arch. Biochem. Biophys. 1996;336:1\u20139. doi: 10.1006/abbi.1996.0525.", "ArticleIdList": ["10.1006/abbi.1996.0525", "8951028"]}, {"Citation": "Jhou B.Y., Song T.Y., Lee I., Hu M.L., Yang N.C. Lycopene Inhibits Metastasis of Human Liver Adenocarcinoma SK-Hep-1 Cells by Downregulation of NADPH Oxidase 4 Protein Expression. J. Agric. Food Chem. 2017;65:6893\u20136903. doi: 10.1021/acs.jafc.7b03036.", "ArticleIdList": ["10.1021/acs.jafc.7b03036", "28723216"]}, {"Citation": "Salehi B., Sharifi-Rad R., Sharopov F., Namiesnik J., Roointan A., Kamle M., Kumar P., Martins N., Sharifi-Rad J. Beneficial effects and potential risks of tomato consumption for human health: An overview. Nutrition. 2019;62:201\u2013208. doi: 10.1016/j.nut.2019.01.012.", "ArticleIdList": ["10.1016/j.nut.2019.01.012", "30925445"]}, {"Citation": "Gulati O.P. Pycnogenol(R) in metabolic syndrome and related disorders. Phytother. Res. 2015;29:949\u2013968. doi: 10.1002/ptr.5341.", "ArticleIdList": ["10.1002/ptr.5341", "25931421"]}, {"Citation": "Schoonees A., Visser J., Musekiwa A., Volmink J. Pycnogenol\u00ae (extract of French maritime pine bark) for the treatment of chronic disorders (Review) Cochrane Datab System Rev. 2012;4:1\u201381. doi: 10.1002/14651858.CD008294.pub4.", "ArticleIdList": ["10.1002/14651858.CD008294.pub4", "22513958"]}, {"Citation": "D\u2019Andrea G. Pycnogenol: A blend of procyanidins with multifaceted therapeutic applications? Fitoterapia. 2010;81:724\u2013736. doi: 10.1016/j.fitote.2010.06.011.", "ArticleIdList": ["10.1016/j.fitote.2010.06.011", "20598812"]}, {"Citation": "Mei L., Mochizuki M., Hasegawa N. Protective effect of Pycnogenol\u00ae on ovariectomyinduced bone loss in rats. Phytother. Res. 2012;26:153\u2013155. doi: 10.1002/ptr.3541.", "ArticleIdList": ["10.1002/ptr.3541", "21710590"]}, {"Citation": "Je-Won K., So-Won P., Na-Rae S., Woong-Il K., Jong-Choon K., In-Sik S., Dong-Ho S. Inhibitory effects of Pycnogenol\u00ae, a pine bark extract, in a rat model of testosterone propionate-induced benign prostatic hyperplasia. Lab. Anim. Res. 2018;34:111\u2013117.", "ArticleIdList": ["PMC6170226", "30310407"]}, {"Citation": "Stanislavov R., Rohdewald P. Sperm quality in men is improved by supplementation with a combination of l-arginine, l-citrullin, roburins and Pycnogenol(R) Ital. J. Urol. Nephrol. 2014;66:217\u2013223.", "ArticleIdList": ["25531191"]}, {"Citation": "Guti\u00e9rrez A., G\u00e1mez R., Mas R., Noa M., Pardo B., Marrero G., P\u00e9rez Y., Gonz\u00e1lez R., Curveco D., Garc\u00eda H. Oral Subchronic Toxicity of a Lipid Extract from Roystonea regia Fruits in Mice. Drug Chem. Toxicol. 2008;31:217\u2013228. doi: 10.1080/01480540701873152.", "ArticleIdList": ["10.1080/01480540701873152", "18330783"]}, {"Citation": "Stewart K. Effects of bark harvest and other human activity on populations of the African cherry (Prunus africana) on Mount Oku, Cameroon. For. Ecol. Manag. 2009;258:1121\u20131128. doi: 10.1016/j.foreco.2009.05.039.", "ArticleIdList": ["10.1016/j.foreco.2009.05.039"]}, {"Citation": "Maiyoa F., Moodleyb R., Singha M. Phytochemistry, cytotoxicity and apoptosis studies of \u03b2-sitosterol-3-Oglucoside and \u03b2-amyrin from Prunus africa. Afr. J. Tradit. Complement Altern. Med. 2016;13:105\u2013112. doi: 10.21010/ajtcam.v13i4.15.", "ArticleIdList": ["10.21010/ajtcam.v13i4.15", "PMC5566133", "28852726"]}, {"Citation": "Papaioannou M., Schleich S., Prade I., Degen S., Roell D., Schubert U., Tanner T., Claessens F., Matusch R., Baniahmad A. The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth. J. Cell Mol. Med. 2009;13:2210\u20132223. doi: 10.1111/j.1582-4934.2008.00426.x.", "ArticleIdList": ["10.1111/j.1582-4934.2008.00426.x", "PMC6512379", "18627423"]}, {"Citation": "Fourneau C., Hocquemiller R., Cav\u00e9 A. Triterpenes from Prunus africana bark. Phytochemistry. 1996;42:1387\u20131389. doi: 10.1016/0031-9422(96)00038-6.", "ArticleIdList": ["10.1016/0031-9422(96)00038-6"]}, {"Citation": "Capasso C., Gaginella T.S., Grandolini G., Izzo A.A. Phytotherapy\u2014A Quick Reference to Herbal Medicine. Springer; Berlin/Heidelberg, Germany: 2003."}, {"Citation": "Andro M.C., Riffaud J.P. Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: A review of 25 years of published experience. Curr. Ther. Res. 1995;56:796\u2013817. doi: 10.1016/0011-393X(95)85063-5.", "ArticleIdList": ["10.1016/0011-393X(95)85063-5"]}, {"Citation": "Kalkman C. The Old-World species of Prunus subg. Laurocerasus including those formerly referred to Pygeum. Blumea. 1965;13:1\u2013174."}, {"Citation": "Paubert-Braquet M., Cave A., Hocquemiller R., Delacroix D., Dupont C., Hedef N., Borgeat P. Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. J. Lipid Mediat. Cell Signal. 1994;9:285\u2013290.", "ArticleIdList": ["7921787"]}, {"Citation": "Paubert-Braquet M., Monboisse J., Servent-Saez N., Serikoff A., Cav\u00e9 A., Hocquemiller R., Dupont C., Fourneau C., Borel J. Inhibition of bFGF and EGF-induced proliferation of 3T3 fibroblasts by extract of Pygeum africanum (Tadenan\u00ae) Biomed. Pharmacother. 1994;48:43s\u201347s. doi: 10.1016/S0753-3322(09)80008-5.", "ArticleIdList": ["10.1016/S0753-3322(09)80008-5"]}, {"Citation": "Zu P., Koch H., Schwery O., Pironon S., Phillips C., Ondo I., Farrell I.W., Nes W.D., Moore E., Wright G.A., et al. Pollen sterols are associated with phylogeny and environment but not with pollinator guilds. New Phytol. 2021;230:1169\u20131184. doi: 10.1111/nph.17227.", "ArticleIdList": ["10.1111/nph.17227", "PMC8653887", "33484583"]}, {"Citation": "Montero M.T., Alonso E., Sainz T. Allergens from rye pollen (Secale cereale): I. Study of protein release by rye pollen during a 19-hour extraction process. Allergen identification. Allergy. 1992;47:22\u201325. doi: 10.1111/j.1398-9995.1992.tb02244.x.", "ArticleIdList": ["10.1111/j.1398-9995.1992.tb02244.x", "1590561"]}, {"Citation": "Ken\u0111el A., Zimmermann B. Chemical Analysis of Pollen by FT-Raman and FTIR Spectroscopies. Front. Plant Sci. 2020;31:352. doi: 10.3389/fpls.2020.00352.", "ArticleIdList": ["10.3389/fpls.2020.00352", "PMC7136416", "32296453"]}, {"Citation": "Schulz V., H\u00e4nsel R., Blumenthal M., Tyler V.E. Rational Phytotherapy. Springer; Berlin/Heidelberg, Germany: 2004."}, {"Citation": "Kimura M., Kimura I., Nakase K., Sonobe T., Mori N. Micturition activity of pollen extract: Contractile effects on bladder and inhibitory effects on urethral smooth muscle of mouse and pig. Planta Med. 1986;2:148\u2013151. doi: 10.1055/s-2007-969102.", "ArticleIdList": ["10.1055/s-2007-969102", "3725935"]}, {"Citation": "Rugendorff E.W., Weidner W., Ebeling L., Buck A.C. Results of Treatment with Pollen Extract (CerniltonR N) in Chronic Prostatitis and Prostatodynia. Br. J. Urol. 1993;71:433\u2013438. doi: 10.1111/j.1464-410X.1993.tb15988.x.", "ArticleIdList": ["10.1111/j.1464-410X.1993.tb15988.x", "8499988"]}, {"Citation": "Yasumoto R., Kawanishi H., Tsujino T., Tsujita M., Nishisaka N., Horii A., Kishimoto T. Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia. Clin. Ther. 1995;17:82\u201387. doi: 10.1016/0149-2918(95)80009-3.", "ArticleIdList": ["10.1016/0149-2918(95)80009-3", "7538904"]}, {"Citation": "European Union herbal monograph on Serenoa repens (W. Bartram) Small, fructus.  [(accessed on 21 June 2021)].  Available online:  www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-serenoa-repens-w-bartram-small-fructus_en.pdf."}, {"Citation": "Gravas S., Samarinas M., Zacharouli K., Karatzas A., Tzortzis V., Koukoulis G., Melekos M. The effect of hexanic extract of Serenoa repens on prostatic inflammation: Results from a randomized biopsy study. World J. Urol. 2019;37:539\u2013544. doi: 10.1007/s00345-018-2409-1.", "ArticleIdList": ["10.1007/s00345-018-2409-1", "30027406"]}, {"Citation": "Ishii I., Wada T., Takara T. Effects of saw palmetto fruit extract intake on improving urination issues in Japanese men: A randomized, double-blind, parallel-group, placebo-controlled study. Food Sci. Nutr. 2020;8:4017\u20134026. doi: 10.1002/fsn3.1654.", "ArticleIdList": ["10.1002/fsn3.1654", "PMC7455929", "32884683"]}, {"Citation": "Hass M.A., Nowak D.M., Leonova E., Levin R.M., Longhurstl P.A. Identification of components of Prunus africana extract that inhibit lipid peroxidation. Phytomedicine. 1999;6:379\u2013388. doi: 10.1016/S0944-7113(99)80063-4.", "ArticleIdList": ["10.1016/S0944-7113(99)80063-4", "11962548"]}, {"Citation": "Calvo M.I., Akerreta S., Cavero R.Y. Pharmaceutical ethnobotany in the riverside of Navarra (Iberian Peninsula) J. Ethnopharmacol. 2011;135:22\u201333. doi: 10.1016/j.jep.2011.02.016.", "ArticleIdList": ["10.1016/j.jep.2011.02.016", "21345364"]}, {"Citation": "Obertreis B., Giller K., Teucher T., Behnke B., Schmitz H. Anti-inflammatory effect of Urtica dioica folia extract in comparison to caffeic malic acid. Arzneimittelforschung. 1996;46:52\u201356.", "ArticleIdList": ["8821518"]}, {"Citation": "Konrad L., M\u00fcller H.H., Lenz C., Laubinger H., Aum\u00fcller G., Lichius J.J. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med. 2000;66:44\u201347. doi: 10.1055/s-2000-11117.", "ArticleIdList": ["10.1055/s-2000-11117", "10705733"]}, {"Citation": "Dreikorn K. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Curr. Urol. Rep. 2000;1:103\u2013109. doi: 10.1007/s11934-000-0044-y.", "ArticleIdList": ["10.1007/s11934-000-0044-y", "12084323"]}, {"Citation": "Durak I., Biri H., Devrim E., S\u00f6zen S., Avci A. Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer. Cancer Biol. Ther. 2004;3:855\u2013897. doi: 10.4161/cbt.3.9.1038.", "ArticleIdList": ["10.4161/cbt.3.9.1038", "15254411"]}, {"Citation": "Chung L.W., Matsuura J., Rocco A.K., Thompson T.C., Miller G.J., Runner M.N. Tissue interactions and prostatic growth: A new mouse model for prostatic hyperplasia. Ann. N. Y. Acad. Sci. 1984;438:394\u2013404. doi: 10.1111/j.1749-6632.1984.tb38301.x.", "ArticleIdList": ["10.1111/j.1749-6632.1984.tb38301.x", "6085455"]}, {"Citation": "Nahata A., Dixit V.K. Ameliorative effects of stinging nettle (Urtica dioica) on testosterone-induced prostatic hyperplasia in rats. Andrologia. 2012;44:396\u2013409. doi: 10.1111/j.1439-0272.2011.01197.x.", "ArticleIdList": ["10.1111/j.1439-0272.2011.01197.x", "21806658"]}, {"Citation": "Tutin T.G. Flora Europaea. Cambridge University Press; Cambridge, UK: 1993."}, {"Citation": "EU Herbal Monograph: Epilobii Herba.  [(accessed on 20 May 2021)].  Available online:  https://www.ema.europa.eu/en/medicines/herbal/epilobii-herba."}, {"Citation": "Piwowarski J.P., Granica S., Stefa\u0144ska J., Kiss A.K. Differences in Metabolism of Ellagitannins by Human Gut Microbiota ex Vivo Cultures. J. Nat. Prod. 2016;79:3022\u20133030. doi: 10.1021/acs.jnatprod.6b00602.", "ArticleIdList": ["10.1021/acs.jnatprod.6b00602", "28006907"]}, {"Citation": "Piwowarski J.P., Bobrowska-Korczak B., Stanis\u0142awska I., Bielecki W., Wrzesien R., Granica S., Krupa K., Kiss A.K. Evaluation of the Effect of Epilobium angustifolium Aqueous Extract on LNCaP Cell Proliferation in In vitro and In Vivo Models. Planta Med. 2017;83:1159\u20131168. doi: 10.1055/s-0043-109372.", "ArticleIdList": ["10.1055/s-0043-109372", "28454190"]}, {"Citation": "Ferrante C., Chiavaroli A., Angelini P., Venanzoni R., Angeles Flores G., Brunetti L., Petrucci M., Politi M., Menghini L., Leone S., et al. Phenolic Content and Antimicrobial and Anti-Inflammatory Effects of Solidago virga-aurea, Phyllanthus niruri, Epilobium angustifolium, Peumus boldus, and Ononis spinosa Extracts. Antibiotics. 2020;11:783. doi: 10.3390/antibiotics9110783.", "ArticleIdList": ["10.3390/antibiotics9110783", "PMC7694769", "33172081"]}, {"Citation": "Egil A.C., Ozdemir B., Gok B., Kecel-Gunduz S., Budama-Kilinc Y. Synthesis, characterization, biological activities and molecular docking of Epilobium parviflorum aqueous extract loaded chitosan nanoparticles. Int. J. Biol. Macromol. 2020;161:947\u2013957. doi: 10.1016/j.ijbiomac.2020.06.066.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.06.066", "32544580"]}, {"Citation": "Esposito C., Santarcangelo C., Masselli R., Buonomo G., Nicotra G., Insolia V., D\u2019Avino M., Caruso G., Buonomo A.R., Sacchi R., et al. Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial. Biomed Pharmacother. 2021;138:111414. doi: 10.1016/j.biopha.2021.111414.", "ArticleIdList": ["10.1016/j.biopha.2021.111414", "33765581"]}, {"Citation": "Ruszov\u00e1 E., Cheel J., P\u00e1vek S., Moravcov\u00e1 M., Hermannov\u00e1 M., Mat\u011bjkov\u00e1 I., Spilkov\u00e1 J., Velebn\u00fd V., Kubala L. Epilobium angustifolium extract demonstrates multiple effects on dermal fibroblasts in vitro and skin photo-protection in vivo. Gen. Physiol. Biophys. 2013;32:347\u2013359. doi: 10.4149/gpb_2013031.", "ArticleIdList": ["10.4149/gpb_2013031", "23817638"]}, {"Citation": "Loing E., Lamarque E., Borel M. New targets in the battle against dandruff. J. Cosmet. Sci. 2017;68:107\u2013113.", "ArticleIdList": ["29465391"]}, {"Citation": "Orlando G., Chiavaroli A., Ferrante C., Recinella L., Leone S., Brunetti L., Di Simone S.C., Menghini L., Petrucci M., Zengin G., et al. Protective effects induced by the food supplement Fluxonorm\u00ae in the lower urinary tract. Eur. Rev. Med. Pharmacol. Sci. 2021;25:3074\u20133082. doi: 10.26355/eurrev_202104_25562.", "ArticleIdList": ["10.26355/eurrev_202104_25562", "33877671"]}, {"Citation": "Hypoxis. The Plant List.  [(accessed on 2 May 2021)].  Available online:  http://www.theplantlist.org/1.1/browse/A/Hypoxidaceae/Hypoxis/"}, {"Citation": "Havenga K., Abay E., Wiesner L., Viljoen A., Steyn D., Hamman J. The In vitro and In Vivo Effects of Hypoxis hemerocallidea on Indinavir Pharmacokinetics: Modulation of Efflux. Planta Med. 2018;84:895\u2013901. doi: 10.1055/a-0607-2743.", "ArticleIdList": ["10.1055/a-0607-2743", "29672818"]}, {"Citation": "Gwaza L., Aweeka F., Greenblatt R., Lizak P., Huang L., Guglielmo B.J. Co-admini-stration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. Int. J. Infect. Dis. 2013;17:1857\u20131861. doi: 10.1016/j.ijid.2013.02.017.", "ArticleIdList": ["10.1016/j.ijid.2013.02.017", "PMC3776002", "23587599"]}, {"Citation": "Jordaan A.E., du Plessis S.S., Aboua Y.G. The Effects of Wild African Potato (Hypoxis hemerocallidea) Supplementation on Streptozotocin-Induced Diabetic Wistar Rats Reproductive Function. Andrology. 2016;5:1000165. doi: 10.4172/2167-0250.1000165.", "ArticleIdList": ["10.4172/2167-0250.1000165"]}, {"Citation": "Solanum lycopersicum L. Plants of the World Online. Kew Science.  [(accessed on 19 May 2021)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:316947-2."}, {"Citation": "Russo A., Capogrosso P., La Croce G., Ventimiglia E., Boeri L., Briganti A., Damiano R., Montorsi F., Salonia A. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin. Drug Saf. 2016;15:1661\u20131670. doi: 10.1080/14740338.2016.1190830.", "ArticleIdList": ["10.1080/14740338.2016.1190830", "27232207"]}, {"Citation": "Cicero A.F.G., Allkanjari O., Vitalone A., Busetto G.M., Cai T., Largan\u00e0 G., Russo G.I., Magri V., Perletti G., della Cuna F.S.R., et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Arch. Ital. Urol. Androl. 2019;91:139\u2013152. doi: 10.4081/aiua.2019.3.139.", "ArticleIdList": ["10.4081/aiua.2019.3.139", "31577095"]}, {"Citation": "Grammatikopoulou M.G., Gkiouras K., Papageorgiou S., Myrogiannis I., Mykoniatis I., Papamitsou T., Bogdanos D.P., Goulis D.G. Dietary factors and supplements influencing prostate specific-antigen (PSA) concentrations in men with prostate cancer and increased cancer risk: An evidence analysis review based on randomized controlled trials. Nutrients. 2020;12:2985. doi: 10.3390/nu12102985.", "ArticleIdList": ["10.3390/nu12102985", "PMC7600271", "33003518"]}, {"Citation": "Hwang E.S., Bowen P.E. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J. Med. Food. 2004;7:284\u2013289. doi: 10.1089/jmf.2004.7.284.", "ArticleIdList": ["10.1089/jmf.2004.7.284", "15383220"]}, {"Citation": "Da Soares N.C.P., Machado C.L., Trindade B.B., do Lima I.C.C., Gimba E.R.P., Teodoro A.J., Takiya C., Borojevic R. Lycopene extracts from different tomato-based food products induce apoptosis in cultured human primary prostate cancer cells and regulate TP53, Bax and Bcl-2 transcript expression. Asian Pac. J. Cancer Prev. 2017;18:339\u2013345. doi: 10.22034/APJCP.2017.18.2.339.", "ArticleIdList": ["10.22034/APJCP.2017.18.2.339", "PMC5454725", "28345329"]}, {"Citation": "Kim H.S., Bowen P., Chen L., Duncan C., Ghosh L., Sharifi R., Christov K. Effects of Tomato Sauce Consumption on Apoptotic Cell Death in Prostate Benign Hyperplasia and Carcinoma. Nutr. Cancer. 2003;47:40\u201347. doi: 10.1207/s15327914nc4701_5.", "ArticleIdList": ["10.1207/s15327914nc4701_5", "14769536"]}, {"Citation": "Cheng H.M., Koutsidis G., Lodge J.K., Ashor A.W., Siervo M., Lara J. Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence. Crit. Rev. Food Sci. Nutr. 2019;59:141\u2013158. doi: 10.1080/10408398.2017.1362630.", "ArticleIdList": ["10.1080/10408398.2017.1362630", "28799780"]}, {"Citation": "Silaste M.L., Alfthan G., Aro A., Kes\u00e4niemi Y.A., H\u00f6rkk\u00f6 S. Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation. Br. J. Nutr. 2007;98:1251\u20131258. doi: 10.1017/S0007114507787445.", "ArticleIdList": ["10.1017/S0007114507787445", "17617941"]}, {"Citation": "Fuentes E.J., Astudillo L.A., Guti\u00e9rrez M.I., Contreras S.O., Bustamante L.O., Rubio P.I., Moore-Carrasco R., Alarc\u00f3n M.A., Fuentes J.A., Gonz\u00e1lez D.E., et al. Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity. Blood Coagul. Fibrinolysis. 2012;23:109\u2013117. doi: 10.1097/MBC.0b013e32834d78dd.", "ArticleIdList": ["10.1097/MBC.0b013e32834d78dd", "22185934"]}, {"Citation": "Riso P., Visioli F., Grande S., Guarnieri S., Gardana C., Simonetti P., Porrini M. Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J. Agric. Food Chem. 2006;54:2563\u20132566. doi: 10.1021/jf053033c.", "ArticleIdList": ["10.1021/jf053033c", "16569044"]}, {"Citation": "Zhao Q., Yang F., Meng L., Chen D., Wang M., Lu X., Chen D., Jiang Y., Xing N. Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-\u03baB, MAPKs, and Nrf2 signaling pathways in rats. Andrology. 2020;8:747\u2013755. doi: 10.1111/andr.12747.", "ArticleIdList": ["10.1111/andr.12747", "PMC7317562", "31880092"]}, {"Citation": "Herzog A., Siler U., Spitzer V., Seifert N., Denelavas A., Hunziker P.B., Hunziker W., Goralczyk R., Wertz K. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J. 2005;19:1\u201324. doi: 10.1096/fj.04-1905fje.", "ArticleIdList": ["10.1096/fj.04-1905fje", "15545302"]}, {"Citation": "Chen J., Song Y., Zhang L. Lycopene/tomato consumption and the risk of prostate cancer: A systematic review and meta-analysis of prospective studie. J. Nutr. Sci. Vitaminol. 2013;59:213\u2013223. doi: 10.3177/jnsv.59.213.", "ArticleIdList": ["10.3177/jnsv.59.213", "23883692"]}, {"Citation": "\u00d8rsted D.D., Bojesen S.E., Nielsen S.F., Nordestgaard B.G. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: A nationwide cohort study of 3,009,258 men. Eur. Urol. 2011;60:691\u2013698. doi: 10.1016/j.eururo.2011.06.016.", "ArticleIdList": ["10.1016/j.eururo.2011.06.016", "21705134"]}, {"Citation": "Cormio L., Cal\u00f2 B., Falagario U., Iezzi M., Lamolinara A., Vitaglione P., Silecchia G., Carrieri G., Fogliano V., Iacobelli S., et al. Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: A phase II prospective, randomized double-blinded, placebo-controlled st. J. Transl. Med. 2021;19:24. doi: 10.1186/s12967-020-02684-3.", "ArticleIdList": ["10.1186/s12967-020-02684-3", "PMC7789791", "33407599"]}, {"Citation": "Edinger M.S., Koff W.J. Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia. Braz. J. Med. Biol. Res. 2006;39:1115\u20131119. doi: 10.1590/S0100-879X2006000800014.", "ArticleIdList": ["10.1590/S0100-879X2006000800014", "16906286"]}, {"Citation": "Schwarz S., Oberm\u00fcller-Jevic U.C., Hellmis E., Koch W., Jacobi G., Biesalski H.K. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr. 2008;138:49\u201353. doi: 10.1093/jn/138.1.49.", "ArticleIdList": ["10.1093/jn/138.1.49", "18156403"]}, {"Citation": "Veeramachaneni S., Ausman L.M., Choi S.W., Russell R.M., Wang X.D. High dose lycopene supplementation increases hepatic cytochrome P4502E1 protein and inflammation in alcohol-fed rats. J. Nutr. 2008;138:1329\u20131335. doi: 10.1093/jn/138.7.1329.", "ArticleIdList": ["10.1093/jn/138.7.1329", "PMC2543121", "18567756"]}, {"Citation": "Pravettoni V., Primavesi L., Farioli L., Brenna O.V., Pompei C., Conti A., Scibilia J., Piantanida M., Mascheri A., Pastorello E.A. Tomato allergy: Detection of IgE-binding lipid transfer proteins in tomato derivatives and in fresh tomato peel, pulp, and seeds. J. Agric. Food Chem. 2009;57:10749\u201310754. doi: 10.1021/jf9022367.", "ArticleIdList": ["10.1021/jf9022367", "19919119"]}, {"Citation": "Asero R. Tomato Allergy: Clinical Features and Usefulness of Current Routinely Available Diagnostic Methods. J. Investig. Allergol. Clin. Immunol. 2013;23:37\u201342.", "ArticleIdList": ["23653972"]}, {"Citation": "Maritime Pine.  [(accessed on 19 May 2021)].  Available online:  https://www.drugs.com/npp/maritime-pine.htm."}, {"Citation": "Oliff B.H.S., Blumenthal M. Scientific and Clinical Monograph for PYCNOGENOL\u00ae. American Botanical Council; Austin, TX, USA: 2019."}, {"Citation": "Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medi-cation with a diverse clinical pharmacology. Int. J. Clin. Pharmacol. Ther. 2002;40:158\u2013168. doi: 10.5414/CPP40158.", "ArticleIdList": ["10.5414/CPP40158", "11996210"]}, {"Citation": "Robertson N.U., Brand A., Visser J. Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Datab System Rev. 2020;9:82\u201394. doi: 10.1002/14651858.CD008294.pub5.", "ArticleIdList": ["10.1002/14651858.CD008294.pub5", "PMC8094515", "32990945"]}, {"Citation": "Rohdewald P. Pleiotropic Effects of French Maritime Pine Bark Extract to Promote Healthy Aging. Rejuvenation Res. 2019;22:210\u2013217. doi: 10.1089/rej.2018.2095.", "ArticleIdList": ["10.1089/rej.2018.2095", "30215292"]}, {"Citation": "Kim S.H., Lee I.C., Baek H.S., Moon C., Bae C.S., Kim S.H. Ameliorative effects of pine bark extract on spermatotoxicity by alpha-chlorohydrin in rats. Phytother. Res. 2014;28:451\u2013457. doi: 10.1002/ptr.5016.", "ArticleIdList": ["10.1002/ptr.5016", "23788506"]}, {"Citation": "Stanislavov R., Rohdewald P. Improvement of erectile function by a combination of French maritime pine bark and ro-burins with aminoacids. Ital. J. Urol. Nephrol. 2015;67:27\u201332.", "ArticleIdList": ["25664962"]}, {"Citation": "Stanislavov R., Nikolova V., Rohdewald P. Improvement of erectile function with Prelox: A randomized, double-blind, placebo-controlled, crossover trial. Int. J. Impot. Res. 2008;20:173\u2013180. doi: 10.1038/sj.ijir.3901597.", "ArticleIdList": ["10.1038/sj.ijir.3901597", "17703218"]}, {"Citation": "Stanislavov R., Nikolova V. Treatment of erectile dysfunction with pycnogenol and l-arginine. J. Sex Marital Ther. 2003;29:207\u2013213. doi: 10.1080/00926230390155104.", "ArticleIdList": ["10.1080/00926230390155104", "12851125"]}, {"Citation": "Ledda A., Belcaro G., Feragalli B., Cornelli U., Dugall M., Corsi M., Cesarone M.R. Benign prostatic hypertrophy: Pycnogenol\u00ae supplementation improves prostate symptoms and residual bladder volume. Minerva Med. 2018;109:280\u2013284. doi: 10.23736/S0026-4806.18.05572-6.", "ArticleIdList": ["10.23736/S0026-4806.18.05572-6", "29947491"]}, {"Citation": "Leisegang K. Chapter 5.6: Herbal medicine used to treat andrological problems. In: Henkel R., Agarwal A., editors. Europe in Herbal Medicine in Andrology. Academic Press; Cambridge, MA, USA: 2021. pp. 165\u2013173."}, {"Citation": "Roystonea. The Plant List.  [(accessed on 19 June 2021)].  Available online:  www.theplantlist.org/tpl1.1/search?q=Roystonea."}, {"Citation": "Cuban Royal Palm (Roystonea regia), national tree of Cuba.  [(accessed on 19 June 2021)].  Available online:  www.cubanaturaleza.org/index.php?option=com_content&view=article&id=30&Itemid=31."}, {"Citation": "Arruzazabala M.L., M\u00e1s R., Yohani P\u00e9rez Y., Ravelo Y., Molina V., Carbajal D. Effect of D-004, a lipid extract from royal palm (Roystonea regia) fruits, on phenylephrine-induced contractions of isolated rat prostate. Rev. Cuba. Farm. 2009;43:1\u20139."}, {"Citation": "Guti\u00e9rrez A., G\u00e1mez R., Noa M., Mas R., Arencibia D., Pardo B., Valle M., Oyarz\u00e1bal A., Curveco D., Garc\u00eda H., et al. One year oral Toxicity of D-004, a lipid extract from Roystonea regia fruits, in Sprague Dawley rats. Food Chem. Toxicol. 2011;49:2855\u20132861. doi: 10.1016/j.fct.2011.07.061.", "ArticleIdList": ["10.1016/j.fct.2011.07.061", "21839798"]}, {"Citation": "Guti\u00e9rrez A., G\u00e1mez R., Noa M., Mas R., Valle M., Mendoza N., Nodal C., P\u00e9rez Y., Oyarz\u00e1bal A., Bucarano I., et al. Long-Term (24 Months) Carcinogenicity Study of D-004, a Lipid Extract from Roystonea regia Fruits, in Sprague Dawley Rats. Int. J. Toxicol. 2015;34:138\u2013150. doi: 10.1177/1091581815576375.", "ArticleIdList": ["10.1177/1091581815576375", "25823441"]}, {"Citation": "ArrebolaI D.F.A., Mart\u00ednez A.G., Men\u00e9ndez R.G., Acosta B.P., S\u00e1nchez D.C., Cambi\u00e1n H.G. Genotoxic assessment of D-004, extract from Roystonea regia fruit, by means of micronuclei assays. Rev. Cuba. Farm. 2009;43:1\u20138."}, {"Citation": "Guzm\u00e1n R., Fern\u00e1ndez J.C., Pedroso M., Fern\u00e1ndez L., Illnait J., Mendoza S., Quiala A.T., Rodr\u00edguez Z., Mena J., Rod\u00edguez A., et al. Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: A 6-month study. Ther. Adv. Urol. 2019;11:1\u201312. doi: 10.1177/1756287219854923.", "ArticleIdList": ["10.1177/1756287219854923", "PMC6560798", "31217822"]}, {"Citation": "Szendrei K., Csupor D., editors. Gy\u00f3gyn\u00f6v\u00e9nyt\u00e1r. Medicina K\u00f6nyvkiad\u00f3 Zrt.; Budapest, Hungary: 2009."}, {"Citation": "Ishani A., MacDonald R., Nelson D., Rutks I., Wilt T.J. Pygeum africanum for the Treatment of Patients with Benign Prostatic Hyperplasia: A Systematic Review and Quantitative Meta-analysis. Am. J. Med. 2000;109:654\u2013664. doi: 10.1016/S0002-9343(00)00604-5.", "ArticleIdList": ["10.1016/S0002-9343(00)00604-5", "11099686"]}, {"Citation": "Kathambi V., Mutie F.M., Rono P.C., Wei N., Munyao J.N., Kamau P., Gituru R.W., Hu G.-W., Wang W.-F. Traditional knowledge, use and conservation of plants by the communities of Tharaka-Nithi County, Kenya. Plant Divers. 2020;42:479\u2013487. doi: 10.1016/j.pld.2020.12.004.", "ArticleIdList": ["10.1016/j.pld.2020.12.004", "PMC7936104", "33733015"]}, {"Citation": "Rasethe M.T., Semenya S.S., Maroyi A. Medicinal Plants Traded in Informal Herbal Medicine Markets of the Limpopo Province, South Africa. Evid.-Based Compl. Alt. 2019;2019:2609532. doi: 10.1155/2019/2609532.", "ArticleIdList": ["10.1155/2019/2609532", "PMC6500648", "31118951"]}, {"Citation": "Karani L.W., Tolo F.M., Karanja S.M., Khayeka-Wandabwa C. Safety of Prunus africana and Warburgia ugandensis in asthma treatment. S. Afr. J. Bot. 2013;88:183\u2013190. doi: 10.1016/j.sajb.2013.07.007.", "ArticleIdList": ["10.1016/j.sajb.2013.07.007"]}, {"Citation": "Mwitari P.G., Ayeka P.A., Ondicho J., Matu E.N., Bii C.C. Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectranthus barbatus. PLoS ONE. 2013;8:e65619.", "ArticleIdList": ["PMC3681961", "23785437"]}, {"Citation": "Abera B. Medicinal plants used in traditional medicine by Oromo people, Ghimbi District, Southwest Ethiopia. J. Ethnobiol. Ethnomed. 2014;10:40. doi: 10.1186/1746-4269-10-40.", "ArticleIdList": ["10.1186/1746-4269-10-40", "PMC4060869", "24885586"]}, {"Citation": "Bandeira S.O., Gaspar F., Pagula F.P. African Ethnobotany and Healthcare: Emphasis on Mozambique. Pharm. Biol. 2011;39:70\u201373. doi: 10.1076/phbi.39.s1.70.0002.", "ArticleIdList": ["10.1076/phbi.39.s1.70.0002", "21554173"]}, {"Citation": "Omara T., Kiprop A.K., Ramkat R.C., Cherutoi J., Kagoya S., Nyangena D.M., Tebo T.A., Nteziyaremye P., Karanja L.N., Jepchirchir A., et al. Medicinal Plants Used in Traditional Management of Cancer in Uganda: A Review of Ethnobotanical Surveys, Phytochemistry, and Anticancer Studies. Evid.-Based Complement Alt. 2020;2020:3529081. doi: 10.1155/2020/3529081.", "ArticleIdList": ["10.1155/2020/3529081", "PMC7102457", "32256639"]}, {"Citation": "Kassa Z., Asfaw Z., Demissew S. An ethnobotanical study of medicinal plants in Sheka Zone of Southern Nations Nationalities and Peoples Regional State, Ethiopia. J. Ethnobiol. Ethnomed. 2020;16:7. doi: 10.1186/s13002-020-0358-4.", "ArticleIdList": ["10.1186/s13002-020-0358-4", "PMC7003439", "32024539"]}, {"Citation": "Stewart K.M. The African cherry (Prunus africana): Can lessons be learned from an over-exploited medicinal tree? J. Ethnopharm. 2003;89:3\u201313. doi: 10.1016/j.jep.2003.08.002.", "ArticleIdList": ["10.1016/j.jep.2003.08.002", "14522426"]}, {"Citation": "Stark D.T., Mtui J.D., Balemba O.B. Review ethnopharmacological survey of plants used in the traditional treatment of gastrointestinal pain, inflammation and diarrhea in Africa: Future perspectives for integration into modern medicine. Animals. 2013;3:158\u2013227. doi: 10.3390/ani3010158.", "ArticleIdList": ["10.3390/ani3010158", "PMC4495512", "26487315"]}, {"Citation": "Maina J.K., Kareru P.G., Gatebe E.G., Rotich H., Githira P.N., Njonge F., Kiman D., Mutembei J.K. Hypoglycemic effects of selected herbal drug formulations from the Kenyan market. J. Nat. Prod. Plant Res. 2014;4:10\u201317."}, {"Citation": "Ochwang\u2019I D.O., Kimwele C.N., Oduma J.A., Gathumbi P.K., Mbaria J.M., Kiama S.G. Medicinal Plants used in treatment and management of cancer in Kakamega County, Kenya. J. Ethnopharmacol. 2014;151:1040\u20131055. doi: 10.1016/j.jep.2013.11.051.", "ArticleIdList": ["10.1016/j.jep.2013.11.051", "24362078"]}, {"Citation": "Koros H., Malombe I., Mwendwa K., Jeruto P., Agevi H., Konje M. Indigenous knowledge, uses, and conservation of Prunus africana (Hook. F.) Kalkman in Nandi Forests. J. Nat. Sci. Res. 2016;6:2224\u20133186."}, {"Citation": "Komakech R., Kang Y., Lee J.-H., Omujal F. A Review of the Potential of Phytochemicals from Prunus africana (Hook F.) Kalkman Stem Bark for Chemoprevention and Chemotherapy of Prostate Cancer. Evid.-Based Compl. Alt. 2017;2017:3014019. doi: 10.1155/2017/3014019.", "ArticleIdList": ["10.1155/2017/3014019", "PMC5327751", "28286531"]}, {"Citation": "Bombardelli E., Morazzoni P. Prunus africana (Hook. F.) Kalm. Fitoterapia. 1997;68:205\u2013218."}, {"Citation": "Kadu C.A.C., Parich A., Schueler S., Konrad H., Muluvi G.M., Eyog-Matig O., Muchugi A., Williams V.L., Ramamonjisoa L., Kapinga C., et al. Bioactive constituents in Prunus africana: Geographical variation throughout Africa and associations with environmental and genetic parameters. Phytochemistry. 2012;83:70\u201378. doi: 10.1016/j.phytochem.2012.06.001.", "ArticleIdList": ["10.1016/j.phytochem.2012.06.001", "22795601"]}, {"Citation": "Thompson R.Q., Katz D., Sheehan B. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health. J. Pharmaceut. Biomed. 2019;163:162\u2013169. doi: 10.1016/j.jpba.2018.10.004.", "ArticleIdList": ["10.1016/j.jpba.2018.10.004", "30316061"]}, {"Citation": "Math\u00e9 G., Hallard M., Bourut C.H., Chenu E. A Pygeum africanum extract with so-called phyto-estrogenic action markedly reduces the volume of true and large prostatic hypertrophy. Biomed. Pharmacother. 1995;49:341\u2013343. doi: 10.1016/0753-3322(96)82662-X.", "ArticleIdList": ["10.1016/0753-3322(96)82662-X", "8562860"]}, {"Citation": "Roell D., Baniahmad A. The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth. Mol. Cell Endocrinol. 2011;332:1\u20138. doi: 10.1016/j.mce.2010.09.013.", "ArticleIdList": ["10.1016/j.mce.2010.09.013", "20965230"]}, {"Citation": "Jena A.K., Vasisht K., Sharma N., Kaur R., Dhingra M.S., Karan M. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species. J. Ethnopharmacol. 2016;190:33\u201345. doi: 10.1016/j.jep.2016.05.052.", "ArticleIdList": ["10.1016/j.jep.2016.05.052", "27235020"]}, {"Citation": "Yablonsky F., Nicolas V., Riffaud J.P., Bellamy F. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibrobalsts. J. Urol. 1997;157:2381\u20132387. doi: 10.1016/S0022-5347(01)64785-2.", "ArticleIdList": ["10.1016/S0022-5347(01)64785-2", "9146675"]}, {"Citation": "Levin R.M., Whitbeck C., Horan P., Bellamy F. Low-dose Tadenan protects the rabbit bladder from bilateral ischemia/reperfusion-induced contractile dysfunction. Phytomedicine. 2005;12:17\u201324. doi: 10.1016/j.phymed.2003.10.002.", "ArticleIdList": ["10.1016/j.phymed.2003.10.002", "15693703"]}, {"Citation": "Quiles M.T., Arb\u00f3s M.A., Fraga A., de Torres I.M., Revent\u00f3s J., Morote J. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH) Prostate. 2010;70:1044\u20131053. doi: 10.1002/pros.21138.", "ArticleIdList": ["10.1002/pros.21138", "20503393"]}, {"Citation": "Mor\u00e1n E., Bud\u00eda A., Broseta E., Boronat F. Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma. Actas Urol\u00f3gicas Espa\u00f1olas. 2013;37:114\u2013119. doi: 10.1016/j.acuro.2012.07.005.", "ArticleIdList": ["10.1016/j.acuro.2012.07.005", "23058996"]}, {"Citation": "Yoshimura Y., Yamaguchi O., Bellamy F., Constantinou C.E. Effect of Pygeum africanum tadenan on micturition and prostate growth of the rat secondary to coadministered treatment and post-treatment with dihydrotestosterone. Urology. 2003;61:474\u2013478. doi: 10.1016/S0090-4295(02)02155-6.", "ArticleIdList": ["10.1016/S0090-4295(02)02155-6", "12597984"]}, {"Citation": "Choo M.S., Bellamy F., Constantinou C.E. Functional evaluation of Tadenan on micturition and experimental prostate growth induced with exogenous dihydrotestosterone. Urology. 2000;55:292\u2013298. doi: 10.1016/S0090-4295(99)00407-0.", "ArticleIdList": ["10.1016/S0090-4295(99)00407-0", "10688098"]}, {"Citation": "Larr\u00e9 S., Camparo P., Comperat E., Boulbe\u2019s D., Haddoum M., Baulande S., Soularue P., Costa P., Cussenot O. Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures. Asian J. Androl. 2012;14:499\u2013504. doi: 10.1038/aja.2011.132.", "ArticleIdList": ["10.1038/aja.2011.132", "PMC3720175", "22198631"]}, {"Citation": "Cristoni A., Di Pierro F., Bombardelli E. Botanical derivatives for the prostate. Fitoterapia. 2000;71:21\u201328. doi: 10.1016/S0367-326X(00)00174-X.", "ArticleIdList": ["10.1016/S0367-326X(00)00174-X", "10930709"]}, {"Citation": "Schmidt M., Polednik C., Roller J., Hagen R. Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells. Oncol. Rep. 2012;29:628\u2013636. doi: 10.3892/or.2012.2145.", "ArticleIdList": ["10.3892/or.2012.2145", "23165347"]}, {"Citation": "Math\u00e9 G., Orbach-Arbouys S., Bizi E., Court B. The so-called phyto-estrogenic action of Pygeum africanum extract. Biomed. Pharmacother. 1995;49:339\u2013340. doi: 10.1016/0753-3322(96)82661-8.", "ArticleIdList": ["10.1016/0753-3322(96)82661-8", "8562859"]}, {"Citation": "Espinosa G. Nutrition and benign prostatic hyperplasia. Curr. Opin. Urol. 2013;23:38\u201341. doi: 10.1097/MOU.0b013e32835abd05.", "ArticleIdList": ["10.1097/MOU.0b013e32835abd05", "23202286"]}, {"Citation": "Wilt T.J., Ishani A., Stark G., MacDonald R., Lau J., Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review. JAMA. 1998;280:1604\u20131609. doi: 10.1001/jama.280.18.1604.", "ArticleIdList": ["10.1001/jama.280.18.1604", "9820264"]}, {"Citation": "Dedhia R.C., McVary K.T. Phytotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J. Urol. 2008;179:2119\u20132125. doi: 10.1016/j.juro.2008.01.094.", "ArticleIdList": ["10.1016/j.juro.2008.01.094", "18423748"]}, {"Citation": "Committee on Herbal Medicinal Products . Overview of Comments Received on European Union Herbal Monograph Prunus africana (Hook f.) Kalkm. Cortex (EMA/HMPC/680626/2013) Committee on Herbal Medicinal Products (HMPC); Vienna, Austria: 2016. pp. 1\u201319."}, {"Citation": "Nicholson T.M., Ricke W.A. Androgens and estrogens in benign prostatic hyperplasia: Past, present and future. Differentiation. 2011;82:184\u2013199. doi: 10.1016/j.diff.2011.04.006.", "ArticleIdList": ["10.1016/j.diff.2011.04.006", "PMC3179830", "21620560"]}, {"Citation": "Dufour B., Choquenet C., Revol M., Faure G., Jorest R. Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma (French) Ann. Urol. 1984;18:193\u2013195.", "ArticleIdList": ["6084978"]}, {"Citation": "Barlet A., Albrecht J., Aubert A., Fischer M., Grof F., Grothuesmann H.G., Masson J.C., Mazeman E., Mermon R., Reichelt H. Wirksamkeit eines extraktes aus Pygeum africanum in der medikamentosen Therapie von Miktionsstorungen infolge einer benignen Prostathyperplasi: Bewertung objektiver und subjektiver Parameter. Wie Klin Wochenschr. 1990;102:667\u2013673.", "ArticleIdList": ["1702916"]}, {"Citation": "Lowe F.C., Dreikhorn K., Borkowski A., Braeckman J., Denis L., Ferrari P., Gerber G., Levin R., Perrin P., Senge T. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH. Prostate. 1998;37:187\u2013193. doi: 10.1002/(SICI)1097-0045(19981101)37:3<187::AID-PROS8>3.0.CO;2-T.", "ArticleIdList": ["10.1002/(SICI)1097-0045(19981101)37:3<187::AID-PROS8>3.0.CO;2-T", "9792136"]}, {"Citation": "Lowe F.C., Fagelman E. Phytotherapy in the treatment of BPH: An update. Urology. 1999;53:671\u2013678. doi: 10.1016/S0090-4295(98)00664-5.", "ArticleIdList": ["10.1016/S0090-4295(98)00664-5", "10197839"]}, {"Citation": "Chatelain A., Autet W., Brackman F. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: A randomized, double-blind study, with long-term open label extension. Urology. 1999;54:473\u2013478. doi: 10.1016/S0090-4295(99)00147-8.", "ArticleIdList": ["10.1016/S0090-4295(99)00147-8", "10475357"]}, {"Citation": "Cornu J.N., Cussenot O., Haab F., Lukacs B. A Widespread Population Study of Actual Medical Management of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia Across Europe and Beyond Official Clinical Guidelines. Eur. Urol. 2010;58:450\u2013456. doi: 10.1016/j.eururo.2010.05.045.", "ArticleIdList": ["10.1016/j.eururo.2010.05.045", "20554374"]}, {"Citation": "Kim T.-H., Lim H.-J., Kim M.-S., Lee M.S. Dietary supplements for benign prostatic hyperplasia: An overview of systematic reviews. Maturitas. 2012;73:180\u2013185. doi: 10.1016/j.maturitas.2012.07.007.", "ArticleIdList": ["10.1016/j.maturitas.2012.07.007", "22883375"]}, {"Citation": "Secale cereale L. Plants of the World Online. Kew Science.  [(accessed on 20 May 2021)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:421164-1."}, {"Citation": "Locatelli M., Macchione N., Ferrante C., Chiavaroli A., Recinella L., Carradori S., Zengin G., Cesa S., Leporini L., Leone S., et al. molecules Graminex Pollen: Phenolic Pattern, Colorimetric Analysis and Protective Effects in Immortalized Prostate Cells (PC3) and Rat Prostate Challenged with LPS. Molecules. 2018;23:1145. doi: 10.3390/molecules23051145.", "ArticleIdList": ["10.3390/molecules23051145", "PMC6100541", "29751604"]}, {"Citation": "El-Khatib F.M., Yafi N.R., Yafi F.A. Effects of Lifestyle on Men\u2019s Health. Elsevier; Amsterdam, The Netherlands: 2019. Over-the-counter supplements and men\u2019s health; pp. 281\u2013300."}, {"Citation": "Ohkoshi M., Kawamura N., Nagakubo I. Clinical Evaluation of Cernilton in Chronic Prostatitis.  [(accessed on 19 May 2021)].  Available online:  https://www.graminex.com/wp-content/uploads/2017/11/Clinical-evaluation-of-Cernilton-in-chronic-prostatitis.pdf."}, {"Citation": "MacDonald R., Ishani A., Rutks I., Wilt T.J. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int. 2000;85:836\u2013841. doi: 10.1046/j.1464-410x.2000.00365.x.", "ArticleIdList": ["10.1046/j.1464-410x.2000.00365.x", "10792162"]}, {"Citation": "Buck A.C., Cox R., Rees R.W.M., Ebeling L., John A. Treatment of Outflow Tract Obstruction due to Benign Prostatic Hyperplasia with the Pollen Extract Cernilton: A Double-blind, Placebo-controlled Study. Br. J. Urol. 1990;66:398\u2013404. doi: 10.1111/j.1464-410X.1990.tb14962.x.", "ArticleIdList": ["10.1111/j.1464-410X.1990.tb14962.x", "1699628"]}, {"Citation": "Roberts K.P., Iyer R.A., Prasad G., Liu L.T., Lind R.E., Hanna P.E. Cyclic hydroxamic acid inhibitors of prostate cancer cell growth: Selectivity and structure activity relationships. Prostate. 1998;34:92\u201399. doi: 10.1002/(SICI)1097-0045(19980201)34:2<92::AID-PROS3>3.0.CO;2-L.", "ArticleIdList": ["10.1002/(SICI)1097-0045(19980201)34:2<92::AID-PROS3>3.0.CO;2-L", "9465940"]}, {"Citation": "Habib F.K., Ross M., Buck A.C., Ebeling L., Lewenstein A. In vitro Evaluation of the Pollen Extract Cernitin T-60, in the Regulation of Prostate Cell Growth. Br. J. Urol. 1990;66:393\u2013397. doi: 10.1111/j.1464-410X.1990.tb14961.x.", "ArticleIdList": ["10.1111/j.1464-410X.1990.tb14961.x", "1699627"]}, {"Citation": "PubMed  Inhibition of Arachidonic Acid Cascade by Extract of Rye Pollen.  [(accessed on 19 May 2021)]; Available online:  https://pubmed.ncbi.nlm.nih.gov/1904229/"}, {"Citation": "Nakase K., Takenaga K., Hamanaka T., Kimura M. Inhibitory effect and synergism of cernitin pollen extract on the urethral smooth muscle and diaphragm of the rat. Folia Pharmacol. Jpn. 1988;91:385\u2013392. doi: 10.1254/fpj.91.385.", "ArticleIdList": ["10.1254/fpj.91.385", "3417212"]}, {"Citation": "Asakawa K., Nandachi N., Satoh S., Honma M., Namikata S., Ishi M., Yasumoto R., Nishisaka N., Masuda C. Effects of cernitin pollen-extract (Cernilton) on inflammatory cytokines in sex-hormone-induced nonbacterial prostatitis rats. Hinyokika Kiyo. 2001;47:459\u2013465.", "ArticleIdList": ["11523128"]}, {"Citation": "Dizeyi N., Mattisson I.Y., Ramnemark L., Grabe M., Abrahamsson P.A. The effects of Cernitin\u00ae on inflammatory parameters and benign prostatic hyperplasia: An in vitro study. Phyther. Res. 2019;33:2457\u20132464. doi: 10.1002/ptr.6438.", "ArticleIdList": ["10.1002/ptr.6438", "31342610"]}, {"Citation": "PubMed  A Comparative Study on Different Doses of Cernilton for Preventing the Clinical Progression of Benign Prostatic Hyperplasia.  [(accessed on 20 May 2021)]; Available online:  https://pubmed.ncbi.nlm.nih.gov/18649754/", "ArticleIdList": ["18649754"]}, {"Citation": "Qian X., Kong X., Qian Y., Xu D., Liu H., Zhu Y., Guan W., Zheng J., Wang Z., Qi J. Therapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate. Int. J. Clin. Exp. Med. 2015;8:11268\u201311275.", "ArticleIdList": ["PMC4565317", "26379934"]}, {"Citation": "Wilt T.J., MacDonald R., Ishani A., Rutks I., Stark G. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 2011;11:CD001042. doi: 10.1002/14651858.CD001042.pub2.", "ArticleIdList": ["10.1002/14651858.CD001042.pub2", "21563128"]}, {"Citation": "Keehn A., Lowe F.C. Complementary and alternative medications for benign prostatic hyperplasia. Can. J. Urol. 2015;1:18\u201323.", "ArticleIdList": ["26497340"]}, {"Citation": "Montero M.T., Alonso E., Sainz T. Allergens from rye pollen (Secale cereale): II. Characterization and partial purification. Allergy. 1992;47:26\u201329. doi: 10.1111/j.1398-9995.1992.tb02245.x.", "ArticleIdList": ["10.1111/j.1398-9995.1992.tb02245.x", "1590562"]}, {"Citation": "Serenoa.  [(accessed on 21 June 2021)].  Available online:  www.theplantlist.org/tpl1.1/search?q=Serenoa."}, {"Citation": "Ross I.A. Medicinal Plants of the World, Vol. 3: Chemical Constituents, Traditional and Modern Medicinal Uses. Humana Press Inc.; Totowa, NJ, USA: 2005. pp. 461\u2013485."}, {"Citation": "Council of Europe: European Directorate for the Quality of Medicines and Healthcare; European Pharmacopoeia: Strasbourg, France; Volume 10, p. 1848. 2021.  [(accessed on 21 June 2021)].  Available online:  https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition."}, {"Citation": "Assessment report on Serenoa repens (W. Bartram) Small, fructus.  [(accessed on 21 June 2021)].  Available online:  www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-serenoa-repens-w-bartram-small-fructus_en.pdf."}, {"Citation": "Cai T., Cui Y., Yu S., Li Q., Zhou Z., Gao Z. Comparison of Serenoa repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Am. J. Men\u2019s Health. 2020;14:1557988320905407. doi: 10.1177/1557988320905407.", "ArticleIdList": ["10.1177/1557988320905407", "PMC7153190", "32274957"]}, {"Citation": "Russo G.I., Scandura C., Di Mauro M., Cacciamani G., Albersen M., Hatzichristodoulou G., Fode M., Capogrosso P., Cimino S., Marcelissen T., et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur. Urol. Focus. 2021;7:420\u2013431. doi: 10.1016/j.euf.2020.01.002.", "ArticleIdList": ["10.1016/j.euf.2020.01.002", "31952967"]}, {"Citation": "Grauso L., de Falco B., Lanzotti V., Motti R. Stinging nettle, Urtica dioica L.: Botanical, phytochemical and pharmacological overview. Phytochem. Rev. 2020;19:1341\u20131377. doi: 10.1007/s11101-020-09680-x.", "ArticleIdList": ["10.1007/s11101-020-09680-x"]}, {"Citation": "Chrubasik J.E., Roufogalis B.D., Wagner H., Chrubasik S. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: Urticae radix. Phytomedicine. 2007;14:568\u2013579.", "ArticleIdList": ["17509841"]}, {"Citation": "Koch E. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): Viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta Med. 2001;67:489\u2013500. doi: 10.1055/s-2001-16496.", "ArticleIdList": ["10.1055/s-2001-16496", "11509966"]}, {"Citation": "Hryb D.J., Khan M.S., Romas N.A. The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes. Planta Med. 1995;61:31\u201332. doi: 10.1055/s-2006-957993.", "ArticleIdList": ["10.1055/s-2006-957993", "7700987"]}, {"Citation": "Sajfrtova M., Sovova H., Opletal L., B\u00e1rtlov\u00e1 M. Near-critical extraction of \u00df-sitosterol and scopoletin from stinging nettle roots. J. Supercrit. Fluids. 2005;35:111\u2013118. doi: 10.1016/j.supflu.2004.12.008.", "ArticleIdList": ["10.1016/j.supflu.2004.12.008"]}, {"Citation": "Testai L., Chericoni S., Calderone V., Nencioni G., Nieri P., Morelli I., Martinotti E. Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: In vitro and in vivo pharmacological studies. J. Ethnopharmacol. 2002;81:105\u2013109. doi: 10.1016/S0378-8741(02)00055-7.", "ArticleIdList": ["10.1016/S0378-8741(02)00055-7", "12020933"]}, {"Citation": "EU Herbal Monograph: Urticae herba.  [(accessed on 20 May 2021)].  Available online:  https://www.ema.europa.eu/en/medicines/herbal/urticae-herba."}, {"Citation": "El Haouari M., Bnouham M., Bendahou M., Aziz M., Ziyyat A., Legssyer A., Mekhfi H. Inhibition of rat platelet aggregation by Urtica dioica leaves extracts. Phytother. Res. 2006;20:568\u2013572. doi: 10.1002/ptr.1906.", "ArticleIdList": ["10.1002/ptr.1906", "16619332"]}, {"Citation": "Daher C.F., Baroody K.G., Baroody G.M. Effect of Urtica dioica extract intake upon blood lipid profile in the rats. Fitoterapia. 2006;77:183\u2013188. doi: 10.1016/j.fitote.2006.01.010.", "ArticleIdList": ["10.1016/j.fitote.2006.01.010", "16540261"]}, {"Citation": "Lichius J.J., Muth C. The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse. Planta Med. 1997;63:307\u2013310. doi: 10.1055/s-2006-957688.", "ArticleIdList": ["10.1055/s-2006-957688", "9270373"]}, {"Citation": "Vontobel H., Herzog R., Rutishauser G., Kreis H. Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia. Urologe A. 1985;24:49\u201351.", "ArticleIdList": ["2580383"]}, {"Citation": "Koch E., Biber A. Pharmakologische Wirkungen von Sabal- und Urtikaextrakten als Grundlage f\u00fcr eine rationale medikament\u00f6se Therapie der benignen Prostatahyperplasie. Urologe B. 1994;34:95\u2013100."}, {"Citation": "Stahl H.P. Die Therapie Prostatischer Nykturie. Z. F\u00fcr Algemeine Med. 1984;60:128\u2013132.", "ArticleIdList": ["6201019"]}, {"Citation": "Friesen A. Statistiche Analyse einer Multizenter-Langzeitstudie mit ERD. Beninge Prostata hyperplasie II. J. Klin. Exp. UraZ. 1988;19:121\u2013130."}, {"Citation": "Dhouibi R., Affes H., Ben Salem M., Hammami S., Sahnoun Z., Zeghal K.M., Ksouda K. Screening of pharmacological uses of Urtica dioica and others benefits. Prog. Biophys. Mol Biol. 2020;150:67\u201377. doi: 10.1016/j.pbiomolbio.2019.05.008.", "ArticleIdList": ["10.1016/j.pbiomolbio.2019.05.008", "31163183"]}, {"Citation": "Safarinejad M.R. Urtica dioica for treatment of benign prostatic hyperplasia: A prospective, randomized, double-blind, placebo-controlled, crossover study. J. Herb. Pharmacother. 2005;5:1\u201311. doi: 10.1080/J157v05n04_01.", "ArticleIdList": ["10.1080/J157v05n04_01", "16635963"]}, {"Citation": "Lopatkin N., Sivkov A., Schl\u00e4fke S., Funk P., Medvedev A., Engelmann U. Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms\u2014Long-term follow-up of a placebo-controlled, double-blind, multicenter trial. Int. Urol. Nephrol. 2007;39:1137\u20131146. doi: 10.1007/s11255-006-9173-7.", "ArticleIdList": ["10.1007/s11255-006-9173-7", "18038253"]}, {"Citation": "Mahboubi M. Urtica dioica in the Management of Benign Prostate Hyperplasia (BPH) Nat. Prod. J. 2020;10:535\u2013542. doi: 10.2174/2210315509666190723125509.", "ArticleIdList": ["10.2174/2210315509666190723125509"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "23"}, {"Year": "2021", "Month": "11", "Day": "19"}, {"Year": "2021", "Month": "11", "Day": "20"}, {"Year": "2021", "Month": "12", "Day": "10", "Hour": "1", "Minute": "7"}, {"Year": "2021", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["34885733", "PMC8659259", "10.3390/molecules26237141", "molecules26237141"]}}], "PubmedBookArticle": []}